I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., 2019, Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis, Proceedings of the National Academy of Sciences of the United States of America, Vol:116, ISSN:0027-8424, Pages:11020-11027
et al., 2019, MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis, Trials, Vol:20, ISSN:1745-6215
et al., Breaking the cycle: reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate, Neurology, Neuroimmunology and Neuroinflammation, ISSN:2332-7812
et al., 2019, Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis, Multiple Sclerosis Journal, Vol:25, ISSN:1352-4585, Pages:653-660
Wilkie D, Solari A, Nicholas R, Initiating disease modifying treatments in multiple sclerosis: measuring the decision process using decisional conflict and decisional regret scales, Multiple Sclerosis Journal - Experimental, Translational and Clinical, ISSN:2055-2173